Gossamer Bio, Inc. (GOSS)

0.4207 -1.71 (-80.25%) USD  |  NASDAQ  |  Feb 23, 16:00
0.3951 -0.03 (-6.09%) After-Hours: 16:59
More

Gossamer Bio EBITDA Estimates for Current Quarter

EBITDA Estimates for Current Quarter Chart

View EBITDA Estimates for Current Quarter for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Estimates for Current Quarter Range, Past 5 Years

View EBITDA Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Estimates for Current Quarter Benchmarks

View EBITDA Estimates for Current Quarter Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. --
Axsome Therapeutics, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade